May 15 |
Compugen Appoints David Silberman as Chief Financial Officer
|
May 6 |
Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024
|
Apr 29 |
We're Not Worried About Compugen's (NASDAQ:CGEN) Cash Burn
|
Apr 25 |
Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024
|
Apr 10 |
Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503
|
Apr 3 |
Compugen to Participate in Two Upcoming Investor Conferences
|
Apr 2 |
Is Compugen Ltd. (NASDAQ:CGEN) Trading At A 31% Discount?
|